Jext (Epinephrine Bitartrate)

Epinephrine acts as a non‑selective agonist at alpha and beta adrenergic receptors. Stimulation of alpha‑1 receptors causes vasoconstriction, raising blood pressure and reducing edema, while beta‑1 activation increases heart rate and contractility. Beta‑2 stimulation relaxes bronchial smooth muscle, producing bronchodilation and inhibiting further release of allergic mediators.

The dose of Jext is determined by the prescribing healthcare professional based on the patient’s age, weight, severity of the reaction, and clinical guidelines. No fixed dosing information is provided here; clinicians should follow local protocols and product labeling.

Safety data for epinephrine in pregnancy and lactation are limited, and the product is classified as having an unknown pregnancy category. Use is only recommended when the potential benefit to the mother outweighs any possible risk to the fetus or infant, and it should be administered under medical supervision.

To place an order, submit an enquiry on the Jext product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including cold‑chain if needed), and the necessary import documentation.

Jext delivers epinephrine in an injectable solution for intramuscular use, similar in action to auto‑injector devices such as adrenaline pens. While auto‑injectors offer convenience and pre‑set dosing, Jext allows clinicians to adjust the volume administered and is often used in hospital or emergency‑room settings where precise dosing and immediate availability are required.

Jext should be stored at ambient temperature, preferably below 25 °C, in its original packaging. Protect the product from moisture, direct sunlight, and extreme temperatures. Do not freeze the solution, and inspect the vial for particulate matter before use.

Jext is administered by intramuscular injection, typically into the anterolateral thigh. The injection site should be cleaned with an alcohol swab, and the needle should be inserted at a 90‑degree angle. Aspiration is recommended to avoid accidental intravascular delivery before delivering the dose.

Serious risks include life‑threatening arrhythmias, severe hypertension or hypertensive crisis, myocardial ischemia, pulmonary edema, and tissue necrosis at the injection site. Patients should be monitored closely for cardiovascular changes, and immediate medical assistance should be sought if any severe symptoms develop.

Jext should not be used in individuals with a known hypersensitivity to epinephrine or any component of the formulation. Caution is advised for patients with uncontrolled cardiovascular disease, severe hyperthyroidism, or those taking non‑selective beta‑blockers, as the drug may have reduced efficacy or increased adverse effects.